NCT03880474View on ClinicalTrials.gov

Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults

PHASE2TerminatedINTERVENTIONAL
Enrollment

2,364

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

October 15, 2019

Study Completion Date

January 21, 2020

Conditions
Influenza
Interventions
BIOLOGICAL

MVA-NP+M1

Trial Vaccine

DRUG

Saline

Sodium Chloride Placebo

Trial Locations (9)

2031

Scientia Clinical Research, Sydney

2148

Paratus Clinical Pty Ltd, Blacktown

2259

Paratus Clinical Pty Ltd, Kanwal

2292

Genesis Research Services, Broadmeadow

3004

Nucleus Network Pty Ltd, Melbourne

4101

Mater Research, South Brisbane

4506

University of Sunshine Coast (USC), Morayfield

4556

University of Sunshine Coast (USC), Sippy Downs

5000

CMAX, Adelaide

Sponsors
All Listed Sponsors
collaborator

Clinical Network Services (CNS) Pty Ltd

INDUSTRY

lead

Barinthus Biotherapeutics

INDUSTRY